CAUTION–Investigational Device. Limited by United States Law to Investigational Use.
Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD® System II for the Treatment of Heart Failure
Corvia Medical Announces Strong Positive One-Year Data from Reduce LAP-HF Clinical Study
Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study
Corvia Medical Receives IDE Approval for REDUCE LAP-HF I Clinical Study & Announces Agreement with Strategic Partner for Exclusive Option to Purchase Company
DC Devices Completes Enrollment In Clinical Trial of the First Transcatheter Device to Treat Diastolic Heart Failure; Announces Name Change to Corvia Medical
DC Devices Closes $34m Series D Financing to Complete Clinical Evaluation of the First Transcatheter Device to Treat Diastolic Heart Failure
DC Devices Secures $9 Million Financing; Lumira Capital Joins Syndicate of Leading Investors